MedicarePartD.guide

A non-government resource built from CMS public data

denosumab biosimilars on AARP Medicare Rx Preferred from UHC (S5921-388)

Jubbonti, Ospomyv and others

Covered.

Tier 4 (non-preferred drug). Quantity limit of 1 per 180 days.

$93.82
Patient pays / month, after deductible
$180.92
Patient pays / month, before the $130.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

JUBBONTI 60 mg/mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $284.30 for a month. Other covered strengths are listed below.

All 2 covered strengths and forms
FormTierPatient pays / monthLimits
JUBBONTI 60 mg/mL Injection4$93.821 per 180 days
STOBOCLO 60 mg/mL Injection4$104.201 per 180 days

Other Osteoporosis drugs on this plan

Verify with the plan before prescribing or filling. Member services: (866)870-3470. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5921-388